Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Medication Access and 
Training Expansion Act of 2019’’ or the ‘‘MATE Act of 
2019’’. 
SEC. 2. REQUIRING PRESCRIBERS OF CONTROLLED SUB-
STANCES 
TO 
COMPLETE 
TRAINING 
ON 
TREATING AND MANAGING PATIENTS WITH 
OPIOID AND OTHER SUBSTANCE USE DIS-
ORDERS. 
(a) IN GENERAL.—Section 303 of the Controlled 
Substances Act (21 U.S.C. 823) is amended by adding at 
the end the following: 
‘‘(l) REQUIRED TRAINING
FOR PRESCRIBERS
ON 
TREATING AND MANAGING PATIENTS WITH OPIOID AND 
OTHER SUBSTANCE USE DISORDERS.— 
‘‘(1) 
APPLICABILITY.—This 
subsection 
ap-
plies— 
‘‘(A) with respect to any practitioner who 
is licensed under State law to prescribe con-
trolled substances; and 
‘‘(B) beginning with the first registration 
or renewal of registration by the practitioner 
under this section occurring 90 or more days 
VerDate Sep 11 2014 
00:04 Nov 13, 2019
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4974.IH
H4974
kjohnson on DSK79L0C42 with BILLS
after the date of enactment of the Medication 
Access and Training Expansion Act of 2019. 
‘‘(2) TRAINING REQUIRED.—As a condition on 
registration under this section to dispense controlled 
substances in schedule II, III, IV, or V, the Attorney 
General shall require any practitioner described in 
paragraph (1)(A) to meet the following: 
‘‘(A) If the practitioner is a physician, the 
practitioner must meet one or more of the fol-
lowing conditions: 
‘‘(i) The physician holds a board cer-
tification in addiction psychiatry or addic-
tion medicine from the American Board of 
Medical Specialties. 
‘‘(ii) The physician holds an addiction 
certification or board certification from the 
American Society of Addiction Medicine or 
the American Board of Addiction Medicine. 
‘‘(iii) The physician holds a board cer-
tification in addiction medicine from the 
American Osteopathic Association. 
‘‘(iv) The physician has, with respect 
to the treatment and management of pa-
tients with opioid and other substance use 
disorders, completed not less than 8 hours 
VerDate Sep 11 2014 
00:04 Nov 13, 2019
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H4974.IH
H4974
kjohnson on DSK79L0C42 with BILLS
of training (through classroom situations, 
seminars at professional society meetings, 
electronic communications, or otherwise) 
that is provided by the American Society of 
Addiction Medicine, the American Acad-
emy of Addiction Psychiatry, the American 
Medical Association, the American Osteo-
pathic Association, the American Psy-
chiatric Association, or any other organiza-
tion that the Secretary determines is ap-
propriate for purposes of this clause. Such 
training shall include— 
‘‘(I) opioid maintenance and de-
toxification; 
‘‘(II) appropriate clinical use of 
all drugs approved by the Food and 
Drug Administration for the treat-
ment of a substance use disorder; 
‘‘(III) initial and periodic patient 
assessments (including substance use 
monitoring); 
‘‘(IV) individualized treatment 
planning, overdose reversal, and re-
lapse prevention; 
VerDate Sep 11 2014 
00:04 Nov 13, 2019
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H4974.IH
H4974
kjohnson on DSK79L0C42 with BILLS
‘‘(V) counseling and recovery 
support services; 
‘‘(VI) staffing roles and consider-
ations; 
‘‘(VII) diversion control; and 
‘‘(VIII) other best practices, such 
as prevention of addiction, as identi-
fied by the Secretary, after consulta-
tion with practitioners from a variety 
of medical specialties and who prac-
tice in different settings in which con-
trolled substances are prescribed. 
‘‘(v) The physician has participated as 
an investigator in one or more clinical 
trials leading to the approval of a narcotic 
drug in schedule III, IV, or V for mainte-
nance or detoxification treatment, as dem-
onstrated by a statement submitted to the 
Secretary by the sponsor of such approved 
drug. 
‘‘(vi) The physician has such other 
training or experience as the State medical 
licensing board of the State where the phy-
sician will provide maintenance or detoxi-
fication 
treatment 
considers 
to 
dem-
VerDate Sep 11 2014 
00:04 Nov 13, 2019
Jkt 099200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H4974.IH
H4974
kjohnson on DSK79L0C42 with BILLS
onstrate the ability of the physician to 
treat and manage patients with opioid and 
other substance use disorders. 
‘‘(vii) The physician has such other 
training or experience as the Secretary 
considers to demonstrate the ability of the 
physician to treat and manage patients 
with opioid and other substance use dis-
orders. Any criteria of the Secretary under 
this clause shall be established by regula-
tion. Any such criteria are effective only 
for 3 years after the date on which the cri-
teria are promulgated, but may be ex-
tended for such additional discrete 3-year 
periods as the Secretary considers appro-
priate for purposes of this clause. Such an 
extension of criteria may only be effec-
tuated through a statement published in 
the Federal Register by the Secretary dur-
ing the 30-day period preceding the end of 
the 3-year period involved. 
‘‘(viii) The physician graduated in 
good standing from an accredited school of 
allopathic medicine or osteopathic medicine 
in the United States during the 5-year pe-
VerDate Sep 11 2014 
00:04 Nov 13, 2019
Jkt 099200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H4974.IH
H4974
kjohnson on DSK79L0C42 with BILLS
riod immediately preceding the date on 
which the physician first registers or re-
news under this section and has success-
fully completed a comprehensive allopathic 
or osteopathic medicine curriculum or ac-
credited medical residency that— 
‘‘(I) included not less than 8 
hours of training on treating and 
managing patients with opioid and 
other substance use disorders; and 
‘‘(II) included, at a minimum— 
‘‘(aa) the training described 
in subclauses (I) through (VIII) 
of clause (iv); and 
‘‘(bb) training with respect 
to any other best practice the 
Secretary determines should be 
included in the curriculum, which 
may include training on pain 
management, including assess-
ment and appropriate use of 
opioid 
and 
non-opioid 
alter-
natives. 
VerDate Sep 11 2014 
00:04 Nov 13, 2019
Jkt 099200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H4974.IH
H4974
kjohnson on DSK79L0C42 with BILLS